Abstract

Lipocalin prostaglandin D synthase (L-PGDS) regulates synthesis of an important inflammatory and signaling mediator, prostaglandin D2 (PGD2). Here, we used structural, biophysical, and biochemical approaches to address the mechanistic aspects of substrate entry, catalysis, and product exit of this enzyme. Structure of human L-PGDS was solved in a complex with a substrate analog (SA) and in ligand-free form. Its catalytic Cys 65 thiol group was found in two different conformations, each making a distinct hydrogen bond network to neighboring residues. These help in elucidating the mechanism of the cysteine nucleophile activation. Electron density for ligand observed in the active site defined the substrate binding regions, but did not allow unambiguous fitting of the SA. To further understand ligand binding, we used NMR spectroscopy to map the binding sites and to show the dynamics of protein-substrate and protein-product interactions. A model for ligand binding at the catalytic site is proposed, showing a second binding site involved in ligand exit and entry. NMR chemical shift perturbations and NMR resonance line-width alterations (observed as changes of intensity in two-dimensional cross-peaks in [¹H,¹⁵N]-transfer relaxation optimization spectroscopy) for residues at the Ω loop (A-B loop), E-F loop, and G-H loop besides the catalytic sites indicate involvement of these residues in ligand entry/egress.

Highlights

  • Lipocalin prostaglandin D synthase (L-PGDS) regulates synthesis of an important inflammatory and signaling mediator, prostaglandin D2 (PGD2)

  • Ligand binding to human L-PGDS Because the biological substrate (PGH2) and product (PGD2) are chemically unstable, analogs were used for binding studies

  • To establish structural information of LPGDS in complex with the substrate and product analog, we first wanted to characterize the binding of these ligands to L-PGDS and to confirm the catalytic activity of the recombinant protein

Read more

Summary

Introduction

Lipocalin prostaglandin D synthase (L-PGDS) regulates synthesis of an important inflammatory and signaling mediator, prostaglandin D2 (PGD2). Structure of human L-PGDS was solved in a complex with a substrate analog (SA) and in ligand-free form. Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase. There are two types of prostaglandin D synthase (PGDS), namely hematopoietic PGDS (H-PGDS) and lipocalin prostaglandin D synthase (L-PGDS) They are distributed in different tissues and distinct in structure; both perform the same catalytic reaction to produce PGD2. L-PGDS is a major PGD2 synthase in the central nervous system, heart, and reproductive tissue, catalyzing the isomerization of PGH2 to PGD2 [6] This protein is involved in pain induction, nephropathy, immunomodulation, adipocyte differentiation, lipid and carbohydrate metabolism, as well as sleep-wake regulation [7,8,9,10,11].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call